COVID-19 Pharmacology

Due to COVID-19, the Bill & Melinda Gates Foundation and others have funded an accelerator program to advance therapeutics to combat the virus and get it to patients, including those in the poorest parts of the world. The objective is to create a central hub for clinical researchers and scientists to share their protocols, studies, progress, and outcomes in the spirit of collaboration and learning. Certara is supporting the research with strategy, stewardship, and development experience and expertise.